| Analysis of circulating tumor DNA to monitor metastatic breast cancer SJ Dawson, DWY Tsui, M Murtaza, H Biggs, OM Rueda, SF Chin, ... New England Journal of Medicine 368 (13), 1199-1209, 2013 | 2470 | 2013 |
| Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA M Murtaza, SJ Dawson, DWY Tsui, D Gale, T Forshew, AM Piskorz, ... Nature 497 (7447), 108-112, 2013 | 1904 | 2013 |
| The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes B Pereira, SF Chin, OM Rueda, HKM Vollan, E Provenzano, HA Bardwell, ... Nature communications 7 (1), 1-16, 2016 | 1555 | 2016 |
| Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA T Forshew, M Murtaza, C Parkinson, D Gale, DWY Tsui, F Kaper, ... Science translational medicine 4 (136), 136ra68-136ra68, 2012 | 1532 | 2012 |
| Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ... Nature communications 6 (1), 8760, 2015 | 511 | 2015 |
| Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid AM Miller, RH Shah, EI Pentsova, M Pourmaleki, S Briggs, N Distefano, ... Nature 565 (7741), 654-658, 2019 | 457 | 2019 |
| Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer MKH Hong, G Macintyre, DC Wedge, P Van Loo, K Patel, S Lunke, ... Nature communications 6 (1), 6605, 2015 | 397 | 2015 |
| Circulating cell-free DNA for non-invasive cancer management CM Stewart, DWY Tsui Cancer Genetics 228, 169-179, 2018 | 131 | 2018 |
| Effect of osimertinib and bevacizumab on progression-free survival for patients with metastatic EGFR-mutant lung cancers: a phase 1/2 single-group open-label trial AY Helena, AJ Schoenfeld, A Makhnin, R Kim, H Rizvi, D Tsui, C Falcon, ... JAMA oncology 6 (7), 1048-1054, 2020 | 120 | 2020 |
| The value of cell‐free DNA for molecular pathology CM Stewart, PD Kothari, F Mouliere, R Mair, S Somnay, R Benayed, ... The Journal of pathology 244 (5), 616-627, 2018 | 117 | 2018 |
| Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre‐eclampsia DWY Tsui, KCA Chan, SSC Chim, L Chan, T Leung, T Lau, YMD Lo, ... Prenatal Diagnosis: Published in Affiliation With the International Society …, 2007 | 96 | 2007 |
| Association of plasma and urinary mutant DNA with clinical outcomes in muscle invasive bladder cancer KM Patel, KE Van Der Vos, CG Smith, F Mouliere, D Tsui, J Morris, ... Scientific reports 7 (1), 5554, 2017 | 94 | 2017 |
| Effects of collection and processing procedures on plasma circulating cell-free DNA from cancer patients B Risberg, DWY Tsui, H Biggs, ARVM de Almagro, SJ Dawson, ... The Journal of Molecular Diagnostics 20 (6), 883-892, 2018 | 93 | 2018 |
| Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS A Rose Brannon, G Jayakumaran, M Diosdado, J Patel, A Razumova, ... Nature Communications 12 (1), 3770, 2021 | 87 | 2021 |
| Measurement of plasma cell-free mitochondrial tumor DNA improves detection of glioblastoma in patient-derived orthotopic xenograft models R Mair, F Mouliere, CG Smith, D Chandrananda, D Gale, F Marass, ... Cancer research 79 (1), 220-230, 2019 | 84 | 2019 |
| Development of genome-derived tumor type prediction to inform clinical cancer care A Penson, N Camacho, Y Zheng, AM Varghese, H Al-Ahmadie, P Razavi, ... JAMA oncology 6 (1), 84-91, 2020 | 83 | 2020 |
| The translational potential of circulating tumour DNA in oncology KM Patel, DWY Tsui Clinical biochemistry 48 (15), 957-961, 2015 | 76 | 2015 |
| Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer DWY Tsui, M Murtaza, ASC Wong, OM Rueda, CG Smith, ... EMBO molecular medicine 10 (6), e7945, 2018 | 68 | 2018 |
| Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): Results from a phase II basket trial. BT Li, R Shen, M Offin, DJ Buonocore, ML Myers, A Venkatesh, P Razavi, ... Journal of Clinical Oncology 37 (15_suppl), 6001-6001, 2019 | 66 | 2019 |
| Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome DWY Tsui, YMD Lam, WS Lee, TY Leung, TK Lau, ET Lau, MHY Tang, ... PloS one 5 (11), e15069, 2010 | 56 | 2010 |
